P, V. L., T, D. C., A, E. M., F, M. P., M, É. B., JM, M. H., . . . J, S. A. (2025). Long-Term Effectiveness, Safety, and Predictive Factors of Tralokinumab Response in Adolescents with Atopic Dermatitis: Insights from a Real-World Multicenter Cohort.
Citación estilo ChicagoP, Villodre Lozano, et al. Long-Term Effectiveness, Safety, and Predictive Factors of Tralokinumab Response in Adolescents With Atopic Dermatitis: Insights From a Real-World Multicenter Cohort. 2025.
Cita MLAP, Villodre Lozano, et al. Long-Term Effectiveness, Safety, and Predictive Factors of Tralokinumab Response in Adolescents With Atopic Dermatitis: Insights From a Real-World Multicenter Cohort. 2025.
Precaución: Estas citas no son 100% exactas.